Stock Details
3349.T is COSMOS Pharmaceutical Corporation's stock. Stock exchange Tokyo (Currency JPY). Average price in 50 days is 14,468.60¥. Average daily volumn in 3 months 215.01k. Market cap 548.44B



Stock symbol : 3349.T. Exchange : Tokyo. Currency : JPY
Lastest price : 13,850.00¥. Total volume : 189.90k. Market state POSTPOST
Click reload if you want to check the lastest price on market!!!

COSMOS Pharmaceutical Corporation (3349.T)
Last Price
13,850.00¥
Change
-220.00
Volume
189.90k

Previous Close14,070.00
Open14,020.00
Day Range13,850.00-14,040.00
Bid13,850.00 x N/A
Ask13,870.00 x N/A
Volume189.9k
Average Volume215.01k
Market Cap548.44B
Beta0.28
52 Week Range10,770.00-18,100.00
Trailing P/E23.44
Foward P/E21.21
Dividend (Yield %)0.60%
Ex-Dividend Date2023-05-30



Financial Details


According to COSMOS Pharmaceutical Corporation's financial reports the company's revenue in 2022 were 755.41B an increase( +3.99%) over the years 2021 revenue that were of 726.42B. In 2022 the company's total earnings were 23.16B while total earnings in 2021 were 27.16B(-14.81%).


Loading ...



Organization

COSMOS Pharmaceutical Corporation operates a chain of drug stores in Japan. As of May 31, 2022, the company operated 1,244 stores in the Kanto, Chubu, Kansai, Chugoku, Shikoku, and Kyushu regions. The company was incorporated in 1983 and is headquartered in Fukuoka, Japan.

Market Cap:
548.44B
Revenue:
755.41B
Total Assets:
363.05B
Total Cash:
37.36B



News about "COSMOS Pharmaceutical Corporation"

COSMOS Pharmaceutical Corp.

Source from : Wall Street Journal - 23 days ago

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...See details»


cosmos-health-enters-the-development-phase-for-ccx0722-an-innovative-product-for-obesity-and-weight-management-image

Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management

Source from : Yahoo - 2 days ago

Cosmos Health, Inc. ("the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical ...See details»


Cosmo Pharmaceuticals NV

Source from : Reuters - 8 days ago

Cosmo Pharmaceuticals N.V. is a pharmaceutical company. The Company is focused on gastroenterology and dermatology. It develops and manufactures products, which are distributed globally.See details»


Is Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Source from : Yahoo - 5 days ago

Most readers would already be aware that Cosmo Pharmaceuticals' (VTX:COPN) stock increased significantly by 20% over the past three months. We wonder if and what role the company's financials play ...See details»


COSMOS Pharmaceutical Stock (OTC:CSMYF), Earnings Estimates, EPS, and Revenue

Source from : Benzinga.com - 29 days ago

COSMOS Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period.See details»


cosmos-health-to-sell-its-sky-premium-life-luxury-food-supplement-brand-on-iberian-airlines-in-flight-magazine-ronda-image

Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda.

Source from : YAHOO!Finance - 11 days ago

Cosmos Health, Inc. ("the Company") (Nasdaq:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical ...See details»


Cosmo Pharmaceuticals Stock (OTC:CMOPF), Guidance and Forecast

Source from : Benzinga.com - 26 days ago

so investors have a sense of how much money a company will make in a future period. There have been no specific sales or earnings guidance reported for Cosmo Pharmaceuticals in recent months.See details»


Cosmo Pharmaceuticals (VTX:COPN) adds €69m to market cap in the past 7 days, though investors from five years ago are still down 60%

Source from : Yahoo! Sports - 1 month ago

Cosmo Pharmaceuticals N.V. (VTX ... One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with ...See details»


COSMOS Pharmaceutical Corp.

Source from : Wall Street Journal - 1 month ago

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...See details»


Cosmo Pharmaceuticals (VTX:COPN) adds €69m to market cap in the past 7 days, though investors from five years ago are still down 60%

Source from : Yahoo Finance - 1 month ago

One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of ...See details»


Is Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Source from : Yahoo Finance - 5 days ago

Most readers would already be aware that Cosmo Pharmaceuticals' (VTX:COPN) stock increased significantly by 20% over the past three months. We wonder if and what role the company's financials play in ...See details»


COSMOS Pharmaceutical Corp.

Source from : Barron's - 1 year ago

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...See details»


Cosmo Pharmaceuticals (VTX:COPN) adds €69m to market cap in the past 7 days, though investors from five years ago are still down 60%

Source from : Yahoo Finance - 1 month ago

One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During five years of ...See details»


COSMOS Pharmaceutical Corp.

Source from : Barron's - 1 year ago

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...See details»